5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.
Published March 26, 2014 · Recall initiated: November 21, 2013
Summary
FDA records drug Class I recall D-1162-2014, published March 26, 2014 and initiated November 21, 2013. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 105,216 containers; Lot: Lot #: P285288, Exp 11/13. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
What to do
Voluntary: Firm initiated · Letter
Get an email if DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DEXTROSE
- Manufacturer
- Baxter Healthcare Corp.
- Distributor
- Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.
- Lot
- Lot #: P285288, Exp 11/13
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524,April 29, 2026
- FDA5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA,April 15, 2026
- FDA5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius KabiApril 15, 2026
- FDA5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA,April 15, 2026
- FDAMarcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials-preservative free, packaged inMarch 26, 2014
- FDA0.9% Sodium Chloride Injection, USP, packaged in a) 50 mL Single dose VIAFLEX plastic containers (Product codeMarch 26, 2014
Questions about this recall
Was 5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38. recalled?
Yes. FDA published recall D-1162-2014 on March 26, 2014. Reported hazard: Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DEXTROSE.